
The WHO Science Division conducted a horizon scan exercise to identify new and emerging innovations in science and technology that could significantly impact global health in the future. The article invites readers to consider the innovations from a public health perspective and to assess their potential benefits and risks.
Recent Posts
HERNEXEOS Lung Cancer Treatment: First FDA Approval for HER2-Mutant NSCLC
FDA Greenlights HERNEXEOS Lung Cancer Treatment as First-Line Option
HERNEXEOS lung cancer treatment (zongertinib tablets), developed by
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 Trial Results
KEYTRUDA Padcev MIBC Survival Breakthrough in Cisplatin-Eligible Patients
KEYTRUDA Padcev MIBC Survival benefits shone in the Phase 3 KEYNOTE-B15 trial, where perioperative KEYTRUDA (pembrolizumab) plus Padce...
Infarmed Regulatory Activity: January 2026 Highlights and Impacts on Market Access
Infarmed regulatory activity in January 2026 showcased robust performance by Portugal's National Authority for Medicines and Health Products, spanning marketing authorizations, clinical trials, public reimbursement, inspections, pharmacovigilance, and enforcement. The agency processed 45 renewals...